Concentrated Power: How the Oxford-Cambridge Axis Is Redrawing the Map of British Research

In the corridors of a mid-sized post-1992 university in the North of England, a senior lecturer in computational biology describes the experience with characteristic understatement. "You write a competitive grant application, you're proud of it, and then you check who won. It's Oxford. Or Cambridge. Or Imperial. You start to wonder whether the game is rigged before you've even sat down."

His frustration is not merely anecdotal. UK Research and Innovation (UKRI) data consistently demonstrates that a handful of institutions — most prominently the Universities of Oxford and Cambridge — attract a share of research council funding that is structurally difficult for the remainder of the sector to challenge. In the 2022–23 financial year, Oxford alone received over £700 million in research income, a figure that exceeds the combined research receipts of many entire regional university clusters. The question this raises is neither simple nor comfortable: does such concentration represent an efficient allocation of resources towards proven excellence, or does it constitute a self-reinforcing hierarchy that gradually erodes the broader ecosystem upon which British science ultimately depends?

The Architecture of Advantage

To understand how the current landscape was constructed, it is necessary to examine the mechanisms that sustain it. Research grant panels frequently reward institutional prestige as a proxy for quality — a phenomenon sometimes referred to as the "Matthew Effect" in science funding, whereby advantage accrues to those who already possess it. Oxford and Cambridge benefit from centuries of accumulated infrastructure: world-class libraries, specialist equipment, dense networks of international collaborators, and — critically — a concentration of doctoral students and postdoctoral researchers who generate the preliminary data required to anchor competitive applications.

This self-reinforcing dynamic is compounded by the Research Excellence Framework (REF), the periodic assessment exercise through which government funding is distributed to universities. While the REF is designed to reward quality rather than reputation, critics argue that its methodology inadvertently favours institutions with the resources to curate high-impact outputs and manage the submission process strategically. Professor Sarah Whitmore, a science policy analyst at the University of Sheffield, has argued in published work that "the REF rewards the ability to perform excellence as much as excellence itself," a distinction with significant distributional consequences.

The View from the Margins

For researchers at institutions outside the traditional elite, the implications are practical as well as symbolic. Smaller universities frequently struggle to offer the matched funding or indirect cost coverage that major grants require. Early-career researchers at these institutions often find themselves in a structural bind: they lack the preliminary data to win large grants, yet without large grants they cannot generate the preliminary data. Many eventually migrate towards better-resourced institutions, not necessarily by choice, but because the alternative is professional stagnation.

Dr Priya Nair, a materials scientist at Coventry University, describes the cumulative effect on departmental culture. "When your most talented colleagues keep leaving for Oxford or Cambridge because that's where the money and the equipment are, it changes what's possible here. You lose critical mass. The seminars get quieter. The collaborations thin out." Her account reflects a wider pattern documented by the Campaign for Science and Engineering, which has repeatedly highlighted the relationship between funding concentration and talent drain from regional institutions.

The consequences extend beyond individual careers. Regional universities frequently serve as the primary source of science graduates for local employers, and their research agendas tend to be more directly responsive to regional economic and social priorities. A funding model that systematically disadvantages these institutions risks widening the already significant gap between the science conducted in elite corridors and the needs of the communities that surround them.

Challenging the Hierarchy

It would be misleading, however, to characterise the situation as entirely static. Several institutions and policy initiatives are actively contesting the established order, with some notable early results. The creation of the Advanced Research and Invention Agency (ARIA) in 2023, modelled loosely on the American DARPA, was explicitly designed to fund high-risk research outside conventional peer-review hierarchies — a structure that, at least in principle, reduces the advantage of institutional prestige.

Meanwhile, a number of regional universities have pursued deliberate strategies to build concentrated excellence in specific domains rather than competing across the board. The University of Leeds has developed internationally recognised clusters in medical imaging and sustainability science. Loughborough University consistently ranks among global leaders in sports science and engineering. Manchester's graphene research programme, anchored by the National Graphene Institute, represents perhaps the most visible example of a post-1992 city successfully establishing a world-class research identity in a genuinely novel field.

These examples suggest that the geography of British research excellence is not immutable, but that challenging the Oxford-Cambridge axis requires sustained institutional commitment, strategic focus, and — inevitably — significant upfront investment that many universities cannot readily secure.

A Question of National Interest

The debate ultimately turns on a fundamental question of science policy: what is the purpose of public research funding? If the primary objective is to maximise short-term citation impact and international league table performance, concentrating resources in a small number of elite institutions may be defensible on utilitarian grounds. Oxford and Cambridge do, after all, produce research of extraordinary quality and international influence.

But if the objectives of public funding are broader — encompassing regional economic development, the cultivation of a scientifically literate workforce, the democratisation of knowledge production, and the long-term resilience of the national research base — then the current distribution pattern gives cause for genuine concern. A system that allows a handful of postcodes to dominate national research capacity is inherently fragile, dependent on the continued excellence of a very small number of institutions whose circumstances could change in ways that are difficult to anticipate.

The lecturer in computational biology in the North of England puts it plainly. "I'm not saying Oxford shouldn't get funding. I'm saying the system should be designed so that good science wins, wherever it's happening. Right now, I'm not sure that's what we've built." Whether British science policy has the will to address that concern remains, for the moment, an open question.